Category: General autoimmunity

T.38 - Unaffected Relatives of Systemic Lupus Erythematosus (sle) Patients Are Discerned by Soluble Mediators, Autoantibodies, and Connective Tissue Disease Questionnaire Scores from Sle Patients and Controls in a Confirmatory Cohort

Thursday, Jun 15
5:45 PM – 7:00 PM

Teresa Aberle

Oklahoma Medical Research Foundation
Oklahoma City, Oklahoma

Gary S. Gilkeson

Medical University of South Carolina
Charleston, South Carolina

Joel M. Guthridge

Oklahoma Medical Research Foundation
Oklahoma City, Oklahoma

John B. Harley

Cincinnati Children’s Hospital Medical Center and US Department of Veterans Affairs Medical Center
Cincinnati, Ohio

Mariko L. Ishimori

Cedars-Sinai Medical Center
Los Angeles, California

Judith A. James

Oklahoma Medical Research Foundation and Oklahoma University Health Sciences Center
Oklahoma City, Oklahoma

Diane L. Kamen

Medical University of South Carolina
Charleston, South Carolina

David R. Karp

University of Texas Southwestern Medical Center
Dallas, Texas

Jill M. Norris

Colorado School of Public Health
Aurora, Colorado

Virginia C. Roberts

Oklahoma Medical Research Foundation
Oklahoma City, Oklahoma

Kathy L. Sivils

Oklahoma Medical Research Foundation
Oklahoma City, Oklahoma

Daniel J. Wallace

Cedars-Sinai Medical Center
Los Angeles, California

Michael H. Weisman

Cedars-Sinai Medical Center
Los Angeles, California

Kendra A. Young

Colorado School of Public Health
Aurora, Colorado

Melissa E. Munroe

Oklahoma Medical Research Foundation
Oklahoma City, Oklahoma